Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dihydroartemisinin-piperaquine efficacy study for uncomplicated falciparum malaria in Laos
ACTRN12618001650280Phase 4Completed
- Sponsor
- Ministry of Health
- Start
- Sep 2016
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of dihydroartemisinin and piperaquine in malaria and Malaria, sponsored by Ministry of Health. Primary endpoint: PCR-corrected treatment success. Started Sep 2016; status: completed.
02
Drugs
dihydroartemisininpiperaquine
03
Conditions
malariaMalaria
Beyond the preview
Go deeper on ACTRN12618001650280.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12618001650280.